Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer.
Gabriel De La Cruz KuDiego Chambergo-MichilotJ Smith Torres-RomanPamela RebazaJoseph PintoJhajaira AraujoZaida MoranteDaniel EnriquezClaudio FloresRenato LuqueAntonella SaavedraMaria LujanHenry GomezBryan ValcarcelPublished in: PloS one (2020)
The NLR is an accessible and reliable biomarker that predicts early mortality among females with mTNBC. Our results suggest that females with high NLR values have poor prognosis despite receiving standard chemotherapy. Health providers should evaluate the possibility to enroll these patients in novel immunotherapy trials.
Keyphrases
- poor prognosis
- end stage renal disease
- long non coding rna
- cardiovascular events
- healthcare
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- small cell lung cancer
- mental health
- risk factors
- prognostic factors
- peritoneal dialysis
- type diabetes
- locally advanced
- cardiovascular disease
- climate change
- health promotion